KBR Signs Letter of Intent to Develop Spaceflight Food Lab at Exploration Park Near Johnson Space Center
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) — KBR (NYSE: KBR), a leader in human spaceflight expertise for more than 60…
Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel…
Railey Molinario Relationship Intelligence Expert Unveils RI, a Scalable Framework for Building Stronger Human Connections
Pioneering a New Era of Relationship Intelligence London, UK, May 22, 2025 (GLOBE NEWSWIRE) — Renowned relationship coaching firm Railey Molinario…
Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)
New York, New York, May 22, 2025 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC,…
IMUNON Announces Withdrawal of Form S-1 Registration Statement
LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with…
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
ImCheck Reports High Remission Rates in AML Patientswith ICT01 Combination Therapy at ASCO 2025 ICT01 in combination with azacitidine and…
ROHM Develops Compact Surface-Mount Near-Infrared LEDs Featuring Industry-Leading Radiant Intensity
ROHM’s Expanded Portfolio of Surface-Mount Near-Infrared (NIR) LEDs Optimized for applications such as VR/AR devices, industrial optical sensors, and human…
Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting
Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting Attachment 2025 05 22 Deliberações da AG EN…
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
· BI 765063 in combination with programmed cell death-1 (PD1) inhibitor antibody ezabenlimab + cetuximab demonstrated a well-tolerated safety profile…
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
New data from the INSIGHT study demonstrates the VeriStrat Host Immune Classifier (HIC)’s ability to predict overall survival in patients…
ImPact Biotech Announces Late-Breaking Podium Presentation at ASCO 2025 Highlighting ENLIGHTED Study Interim Analysis
— Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted…
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodies Long-term outcomes and survival data for…
↑